StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.84−0.07 (-3.91%)

Close on Nov 20, 2026Market cap $146.95MP/E –Yield –

NervGen Pharma shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 72M, up 7.4% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202572M+7.4%
FY2024Dec 31, 202467M–

More NervGen Pharma figures

See a number that looks wrong?